🇺🇸 FDA
Pipeline program

REC-4881

REC-4881-201

Phase 2 small_molecule active

Quick answer

REC-4881 for Familial Adenomatous Polyposis is a Phase 2 program (small_molecule) at RECURSION PHARMACEUTICALS, INC. with 1 ClinicalTrials.gov record(s).

Program details

Company
RECURSION PHARMACEUTICALS, INC.
Indication
Familial Adenomatous Polyposis
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials